Ask AI
ALPINE Long-term Extension Study of Zanubrutinib in Relapsed or Refractory CLL/SLL

Activity

Progress
1 2 3
Course Completed
Activity Information

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: March 24, 2026

Expiration: September 23, 2026